Cukurova Score Validation Study
Conditions: Epithelial Ovarian Cancer; Primary Cytoreduction Sponsors: Cukurova University; Mu ğla Sıtkı Koçman University; Sakarya University; Gazi University; Ankara Etlik City Hospital; Kayseri City Hospital; Mersin University; Selçuk University; Bezmialem Vakif University; Uludag University; Mersin City Hospital; Marmara University; Prof. Dr. Cemil Tascıoglu City Hospital; Ankara Un iversity; Ege University; Hacettepe University; Akdeniz University; Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital; Mustafa Kemal University; Trakya University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy in Recurrent Epithelial Ovarian Cancer
Conditions: Ovarian Cancer Interventions: Biological: Innocell Autologous Cellular Immunotherapy Sponsors: PhotonPharma, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test
Conditions: Epithelial Ovarian Cancer; Adnexal Mass Sponsors: Chongqing University Cancer Hospital; Zhejiang Cancer Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; The First Affiliated Hospital of Zhengzhou University; 3D Medicines Corporation Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC
Conditions: Epithelial Ovarian Cancer Interventions: Biological: Neoantigen polypeptide vaccine Sponsors: Second Affiliated Hospital of Wenzhou Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer
Conditions: Epithelial Ovarian Cancer; Stage III Ovarian Cancer; Stage IV Ovarian Cancer Sponsors: The First Hospital of Jilin University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
Conditions: Ovary Neoplasm; Ovarian Cancer; Epithelial Ovarian Cancer; Recurrent Interventions: Biological: iC9-CAR.B7-H3 T cells; Drug: Cyclophosphamide; Drug: Fludarabine Sponsors: UNC Lineberger Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors
Conditions: Thymic Epithelial Tumor; Thymic Carcinoma; Thymoma; Thymoma and Thymic Carcinoma Interventions: Diagnostic Test: Artificial Intelligence Diagnostics; Diagnostic Test: Recurrence Prediction Tool Sponsors: Erasmus Medical Center; Maastro Clinic, The Netherlands; Hospices Civils de Lyon Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer
Conditions: Recurrent Ovarian Carcinoma Interventions: Procedure: Carboplatin or cisplatin; Drug: Paclitaxel, gemcitabine or liposomal doxorubicin with or without bevacizumab or biosimilar; Drug: Bevacizumab or biosimilar; Procedure: Cytoreductive surgery Sponsors: The University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
Administration of Hyperthermic Intraperitoneal Chemotherapy in the General Ward
Conditions: Epithelial Ovarian Cancer Interventions: Procedure: China Hyperthermic Intraperitoneal Chemotherapy(C-HIPEC) Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Shenshan Medical Center, Memorial Hospital of Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
Conditions: Thymoma; Thymic Carcinoma Interventions: Drug: Sacituzumab govitecan-hziy Sponsors: Georgetown University; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors
Conditions: Neoplasm Malignant Interventions: Biological: STRO-002 Sponsors: Tasly Pharmaceutical Group Co., Ltd; Sutro Biopharma, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Effect of Early Enteral Nutrition on Postoperative Recovery of Ovarian Cancer Patients
Conditions: Advanced Epithelial Ovarian Cancer Interventions: Device: Transnasal jejunal tube; Other: Transvenous access Sponsors: Luo Chengyan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Evaluating the Impact of Synthetic Cooling Agents in Combustible Cigarettes on Smoking Perceptions and Use
Conditions: Cigarette Smoking-Related Carcinoma Interventions: Behavioral: Non-menthol Cigarette Smoking; Behavioral: Menthol Cigarette Smoking; Behavioral: Synthetic Cooling Agent Cigarette Smoking; Behavioral: Usual Brand Cigarette Smoking; Diagnostic Test: Spirometry; Other: Questionnaire Administration; Diagnostic Test: Nasal Epithelial Lining Fluid Sponsors: Ohio State University Comprehensive Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
SUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive Surgery
Conditions: Epithelial Ovarian Cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms Interventions: Procedure: Cytoreductive surgery; Drug: Neoadjuvant chemotherapy; Drug: Adjuvant chemotherapy Sponsors: Clinica Universidad de Navarra, Universidad de Navarra; Asociaci ón de Amigos de la Universidad de Navarra Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
The prevention of rectovaginal fistula after rectal cancer surgery by packing with laparoscopic dislocated fat flap containing ovarian vascular pedicle anterior to the anastomotic stoma: a parallel group randomized controlled trial protocol
In this study, we introduce a new method to prevent RVF during rectal cancer radical operation.MethodsIn this randomized controlled trial (RCT), all operations are performed according to the principle of total mesorectal excision (TME) radical resection in rectal cancer surgery. All eligible participants will be divided into two groups: the experimental group and the control group. Experimental group: the anterior rectal wall of about 1 cm distal to the anastomosis was dislocated. Before the anastomosis of the rectal end, a fat flap (usually left side) containing the ovarian vascular pedicle was dislocated, measured by 1...
Source: Trials - January 18, 2024 Category: Research Source Type: clinical trials
